JohnHFettingMD
Oncology • Lutherville, MDAssociate Professor of Oncology, Associate Professor of Medicine, Assistant Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine; Associate Director for Clinical Practice
Are you Dr. Fetting?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 124 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10803 Falls Road
Pavilion Iii Ste 1500
Lutherville, MD 21093Phone+1 410-583-2970Fax+1 410-583-2980
Summary
- Dr. John Fetting, MD is an oncologist in Lutherville, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center.
Education & Training
Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1977 - 1980
Johns Hopkins UniversityResidency, Internal Medicine, 1975 - 1977- Johns Hopkins University School of MedicineClass of 1975
Certifications & Licensure
MD State Medical License 1975 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Top MD Consumers Checkbook
Clinical Trials
- Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer Start of enrollment: 2014 Jan 16
Publications & Presentations
PubMed
- 1 citationsFeasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App.Karen Lisa Smith, Hua-Ling Tsai, David Lim, Chenguang Wang, Raquel Nunes
JCO Oncology Practice. 2023-11-01 - 6 citationsOlaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.Elaine M Walsh, Neha Mangini, John Fetting, Deborah Armstrong, Isaac S Chan
Clinical Breast Cancer. 2022-06-01 - 17 citationsAssociation of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation.Karen Lisa Smith, Neha Verma, Amanda L Blackford, Jennifer Lehman, Kelly Westbrook
NPJ Breast Cancer. 2022-04-21
Grant Support
- Clinical OncologyNational Cancer Institute1994–1996
- Clinical Oncology Research Career Development ProgramNational Cancer Institute1993
Professional Memberships
- Member
